Histone Deacetylase Inhibitor Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
SNDX | D | Syndax Pharmaceuticals, Inc. | -2.81 | |
MEIP | F | MEI Pharma, Inc. | 0.71 |
Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
Related Stock Lists:
Cancer
Clinical Medicine
Medicine
Solid Tumors
Antineoplastic Drugs
Benzamides
Breast Cancer
Cancer Cell
Cancer Therapies
Clinical Development
Hematological Malignancies
Lung Cancer
National Cancer Institute
Novogen
Pyridines
Refractory Solid Tumors
Treatment Of Breast Cancer
Treatment Of Cancer
Virotherapy
Related ETFs - A few ETFs which own one or more of the above listed Histone Deacetylase Inhibitor stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
CNCR | F | Loncar Cancer Immunotherapy ETF | 1.39 | |
SBIO | D | ALPS Medical Breakthroughs ETF | 1.3 | |
BBC | D | Virtus LifeSci Biotech Clinical Trials ETF | 0.85 | |
XBI | C | SPDR S&P Biotech ETF | 0.52 | |
BTEC | C | Principal Healthcare Innovators Index ETF | 0.4 |
Compare ETFs
Related Industries:
Biotechnology
Drug Manufacturers - Specialty & Generic
Related Stock Lists:
Cancer
Clinical Medicine
Medicine
Solid Tumors
Antineoplastic Drugs
Benzamides
Breast Cancer
Cancer Cell
Cancer Therapies
Clinical Development
Hematological Malignancies
Lung Cancer
National Cancer Institute
Novogen
Pyridines
Refractory Solid Tumors
Treatment Of Breast Cancer
Treatment Of Cancer
Virotherapy
- Histone Deacetylase Inhibitor
Histone deacetylase inhibitors (HDAC inhibitors) are a class of drugs that inhibit the activity of histone deacetylases, enzymes that modify the structure of chromatin by removing acetyl groups from histones. HDAC inhibitors are used to treat a variety of diseases, including cancer, and have been studied as potential treatments for neurodegenerative diseases.
Recent Comments
- TraderMike on Bollinger Band Squeeze
- TraderMike on Bollinger Band Squeeze
- OpenCat584 on Bollinger Band Squeeze
- Dr_Duru on Expansion Breakout
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
From the Blog
Featured Articles